Testing effectiveness (Phase 2)Active Not RecruitingNCT06232655What this trial is testingCladribine Venetoclax in Monocytic AMLWho this might be right forAcute Myeloid Leukemia University of Colorado, Denver 10
Early research (Phase 1)Study completedNCT01727778What this trial is testingSafety and Preliminary Efficacy Study of the Antibody PAT-SM6 in Patients With Relapsed or Refractory Multiple MyelomaWho this might be right forDrug Safety Patrys Ltd. 12
Not applicableUnknownNCT01187121What this trial is testingEvaluating A Drug Testing and Graduated Sanctions Program in DelawareWho this might be right forProbationary FailureRecidivismDrug Relapse University of Delaware 800
Testing effectiveness (Phase 2)Study completedNCT01421667What this trial is testingBrentuximab Vedotin in Relapsed or Refractory Non-Hodgkin LymphomaWho this might be right forLymphoma, B-CellLymphoma, Large B-Cell, DiffuseLymphoma, Non-Hodgkin+1 more Seagen Inc. 176
Not applicableStudy completedNCT01235455What this trial is testingPortuguese Observational Survey to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon by Using Elements of the BetaPlus Program - Nurse Support, Auto-injectorsWho this might be right forRelapsing Remitting Multiple Sclerosis (RRMS)Secondary Progressive Multiple Sclerosis (SPMS) Bayer 10
Testing effectiveness (Phase 2)Looking for participantsNCT05704621What this trial is testingSecondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor MaintenanceWho this might be right forOvarian CancerDrug Related Neoplasm/Cancer Korea University Guro Hospital 124
Large-scale testing (Phase 3)Looking for participantsNCT07188558What this trial is testingInvestigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell TherapyWho this might be right forLarge B-cell LymphomaLymphoma, B-CellRelapsed Non-Hodgkin Lymphoma+6 more Lyell Immunopharma, Inc. 400
Not applicableStudy completedNCT01320748What this trial is testingFMRI Study of a Dual Process Treatment Protocol With Substance Dependent AdultsWho this might be right forSubstance AbuseSubstance DependenceAlcohol Abuse+2 more Inova Health Care Services 29
Testing effectiveness (Phase 2)UnknownNCT02886559What this trial is testingChidamide Plus DCAG for Relapsed/Refractory AMLWho this might be right forAMLRelapse Chinese PLA General Hospital 100
Large-scale testing (Phase 3)Looking for participantsNCT07197580What this trial is testingPhase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCCWho this might be right forccRCCRenal Cell Carcinoma (Kidney Cancer)Renal Cell Carcinoma (RCC)+3 more Telix Pharmaceuticals (Innovations) Pty Limited 40
Early research (Phase 1)Looking for participantsNCT07002112What this trial is testingThe CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relapsed/Refractory B-cell MalignanciesWho this might be right forRelapsed/Refractory B-cell Malignancies The First Affiliated Hospital with Nanjing Medical University 30
Post-approval studies (Phase 4)UnknownNCT04048577What this trial is testingA Pilot Study to Characterize the Biological Effect of a Pre-planned 12 Week Dose Interruption of NatalizumabWho this might be right forMultiple SclerosisMultiple Sclerosis, Relapsing-Remitting Berkovich, Regina MD, PhD Inc. 10
Post-approval studies (Phase 4)Study completedNCT00381355What this trial is testingRCT of a Written Action Plan vs. Usual Care in Children With Acute AsthmaWho this might be right forAsthma McGill University Health Centre/Research Institute of the McGill University Health Centre 218
Testing effectiveness (Phase 2)Study completedNCT01621568What this trial is testingSunitinib for Advanced Thymus Cancer Following Earlier TreatmentWho this might be right forThymomaThymus Neoplasms National Cancer Institute (NCI) 56
Post-approval studies (Phase 4)UnknownNCT03580876What this trial is testingAddition of Azathioprine in IBD Patients With Immunogenic FailureWho this might be right forClinical Failure After Switch Védrines, Philippe, M.D. 90
Testing effectiveness (Phase 2)UnknownNCT04458389What this trial is testingTY101 for Locally Advanced /Metastatic Solid Tumors and Relapsed or Refractory LymphomasWho this might be right forLocally Advanced /Metastatic Solid TumorsRelapsed or Refractory Lymphomas Tayu Huaxia Biotech Medical Group Co., Ltd. 268
Early research (Phase 1)Active Not RecruitingNCT06334991What this trial is testingStudy for Participants With Relapsed/Refractory Non-Hodgkin LymphomaWho this might be right forNon-Hodgkin Lymphoma Refractory/ Relapsed ImmunityBio, Inc. 20
Not applicableStudy completedNCT00918671What this trial is testingMedication-overuse Headache: 4 Years Follow upWho this might be right forMedication Overuse Headache Norwegian University of Science and Technology 60
Not applicableWithdrawnNCT04985357What this trial is testingDefining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsWho this might be right forStage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more Travera Inc
Post-approval studies (Phase 4)Looking for participantsNCT04704999What this trial is testingSoutheast Asia Dose Optimization of TafenoquineWho this might be right forPlasmodium Vivax Malaria University of Oxford 820